Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-cen
Determine whether patients exhibit early functional improvement after minimally-invasive placement of Illuminoss photodynamic nails for peri-acetabular pelvic metastasis at 3 months following procedure
| Condition(s) | Pelvic Metastasis |
|---|---|
| Status | Recruiting |
| Phase | Phase 1 |
| Study type | Interventional |
| Summary | Determine whether patients exhibit early functional improvement after minimally-invasive placement of Illuminoss photodynamic nails for peri-acetabular pelvic metastasis at 3 months following procedure |
| Who can participate | Inclusion Criteria: * Patients must have a histologically confirmed malignancy from prior biopsy of the primary tumor or a metastatic site. Patients with carcinoma, myeloma, and lymphoma may be included in the study. Patients should have metastatic involvement of the periacetabular region that is visible radiographically. Biopsy of acetabular disease is not required for this study. * Age ≥18 years (Illuminoss is approved only for skeletally mature patients) * Suitable candidate for general anesthesia * Ability to understand and the willingness to sign a written informed consent document. * Able and willing to fill out pre-operative and post-operative functional outcome surveys * Absolute neutrophil count ≥ 1,500/mcL * Platelets ≥ 50,000/mcL Exclusion Criteria: * Patients with uncontrolled |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | M.D. Anderson Cancer Center |
| Locations | Houston, Texas, United States |
| Start date | 2023-10-06 |
| NCT ID | NCT06083896 |
| Official listing | https://clinicaltrials.gov/study/NCT06083896 |